James Gibney
Overview
Explore the profile of James Gibney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
778
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morrison L, Dyer A, Dolphin H, Batten I, Reddy C, Widdowson M, et al.
Brain Behav Immun Health
. 2024 Oct;
41:100862.
PMID: 39350951
Midlife cardiovascular risk factors such as Type 2 Diabetes (T2DM) and obesity are associated with the later development of cognitive impairment and dementia. Systemic inflammation is postulated as a crucial...
2.
Paul A, Toale C, Egan M, Whelan M, Feeney J, Crowther S, et al.
Ir J Med Sci
. 2024 Sep;
193(6):2941-2947.
PMID: 39230649
Background: Adrenal myelolipomas are rare, benign, tumours of the adrenal cortex. Aims: This study reports the experience of a tertiary adrenal surgery referral centre's approach to the management of patients...
3.
Morrison L, Dyer A, Dolphin H, Killane I, Bourke N, Widdowson M, et al.
Sensors (Basel)
. 2024 Jun;
24(12).
PMID: 38931687
Midlife risk factors such as type 2 diabetes mellitus (T2DM) confer a significantly increased risk of cognitive impairment in later life with executive function, memory, and attention domains often affected...
4.
Dineen R, Martin-Grace J, Ahmed K, Taylor A, Shaheen F, Schiffer L, et al.
J Clin Endocrinol Metab
. 2023 Jun;
108(12):3178-3189.
PMID: 37339332
Background: Patients with adrenal insufficiency (AI) require life-long glucocorticoid (GC) replacement therapy. Within tissues, cortisol (F) availability is under the control of the isozymes of 11β-hydroxysteroid dehydrogenase (11β-HSD). We hypothesize...
5.
Dyer A, Batten I, Reddy C, Townsend L, Woods C, ONeill D, et al.
Front Immunol
. 2022 Oct;
13:1021351.
PMID: 36311713
Midlife Type 2 Diabetes Mellitus (T2DM) is associated with an increased risk of Alzheimer Disease (AD) in later life, with altered inflammatory responses postulated as key pathological drivers. Previous studies...
6.
Herings P, Dyer A, Kennelly S, Reid S, Killane I, McKenna L, et al.
Sensors (Basel)
. 2022 Aug;
22(15).
PMID: 35957266
Type 2 Diabetes Mellitus (T2DM) in midlife is associated with a greater risk of dementia in later life. Both gait speed and spatiotemporal gait characteristics have been associated with later...
7.
Gargan M, Lee E, OSullivan M, Egan M, Gibney J, Crowther S, et al.
Br J Radiol
. 2021 Nov;
95(1129):20210642.
PMID: 34735299
Objective: Adrenal adenomas are frequently picked up incidentally on cross-sectional imaging and are known to have a classic imaging appearance on CT and MRI. However, not all adrenal adenomas have...
8.
Dineen R, Martin-Grace J, Ahmed K, Frizelle I, Gunness A, Garrahy A, et al.
Eur J Endocrinol
. 2021 Jan;
184(2):253-265.
PMID: 33513125
Background: Adrenal insufficiency (AI) is associated with increased cardiovascular morbidity and mortality and reduced quality of life (QoL). Optimum glucocorticoid (GC) dosing and timing are crucial in the treatment of...
9.
Dyer A, McKenna L, Batten I, Jones K, Widdowson M, Dunne J, et al.
Front Aging Neurosci
. 2021 Jan;
12:605878.
PMID: 33424582
Midlife Type 2 Diabetes Mellitus (T2DM) is associated with a greater risk of dementia in later life. Peripheral inflammation and its impact on cognition is proposed as one of the...
10.
Ahmed M, Byrne R, Pazderska A, Segurado R, Guo W, Gunness A, et al.
Diabetologia
. 2020 Nov;
64(3):656-667.
PMID: 33169205
Aims/hypothesis: The prevalence of atherosclerosis is increased in type 1 diabetes despite normal-to-high HDL-cholesterol levels. The cholesterol efflux capacity (CEC) of HDL is a better predictor of cardiovascular events than...